04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
Male adults, children and teens, and people with water-related jobs have the highest risk of drownin...
Read More >
On June 13, 2019, the U.S. Seventh Circuit Court of Appeals in Miller v. Southwest Airlines, Co., Ca...
Read More >
In a 2-1 decision, the Fifth Circuit Court of Appeals has upheld a district court ruling that the in...
Read More >
The new state law reflects a trend among other states including New Hampshire, Maine, Maryland, Oreg...
Read More >
Running a restaurant is hard. It’s long hours, short tempers and fickle customers. But add in thos...
Read More >
Speech Pathology Group (SPG), a portfolio company of Ridgemont Equity Partners, has acquired Compreh...
Read More >